199 related articles for article (PubMed ID: 32199549)
21. Stepped Care for Opioid Use Disorder Train the Trainer (SCOUTT) initiative: Expanding access to medication treatment for opioid use disorder within Veterans Health Administration facilities.
Gordon AJ; Drexler K; Hawkins EJ; Burden J; Codell NK; Mhatre-Owens A; Dungan MT; Hagedorn H
Subst Abus; 2020; 41(3):275-282. PubMed ID: 32697170
[TBL] [Abstract][Full Text] [Related]
22. Outpatient care for opioid use disorder among the commercially insured: Use of medication and psychosocial treatment.
Busch AB; Greenfield SF; Reif S; Normand ST; Huskamp HA
J Subst Abuse Treat; 2020 Aug; 115():108040. PubMed ID: 32600627
[TBL] [Abstract][Full Text] [Related]
23. Comparative Effectiveness Associated With Buprenorphine and Naltrexone in Opioid Use Disorder and Cooccurring Polysubstance Use.
Xu KY; Mintz CM; Presnall N; Bierut LJ; Grucza RA
JAMA Netw Open; 2022 May; 5(5):e2211363. PubMed ID: 35536575
[TBL] [Abstract][Full Text] [Related]
24. Development and validation of a claim-based provider-level measurement of use of medications to treat opioid use disorder.
Dowd WN; Barch DH; Seibert JH; Mark TL
J Subst Abuse Treat; 2022 Sep; 140():108824. PubMed ID: 35780730
[TBL] [Abstract][Full Text] [Related]
25. Treatment History and Interest in Injectable Opioid Agonist Treatment With Hydromorphone Among People Who Inject Drugs.
Ohlendorf E; Perez-Correa A; Riback L; Ghiroli M; Lopez-Castro T; Fox AD
J Addict Med; 2023 May-Jun 01; 17(3):e148-e155. PubMed ID: 37267166
[TBL] [Abstract][Full Text] [Related]
26. The impact of military sexual trauma and gender on receipt of evidence-based medication treatment among veterans with opioid use disorder.
Beckman KL; Williams EC; Hebert P; Hawkins EJ; Littman AJ; Lehavot K
J Subst Abuse Treat; 2022 Aug; 139():108775. PubMed ID: 35317959
[TBL] [Abstract][Full Text] [Related]
27. Racial inequity in medication treatment for opioid use disorder: Exploring potential facilitators and barriers to use.
Hollander MAG; Chang CH; Douaihy AB; Hulsey E; Donohue JM
Drug Alcohol Depend; 2021 Oct; 227():108927. PubMed ID: 34358766
[TBL] [Abstract][Full Text] [Related]
28. Simulating the experience of searching for LGBTQ-specific opioid use disorder treatment in the United States.
Paschen-Wolff MM; Velasquez R; Aydinoglo N; Campbell ANC
J Subst Abuse Treat; 2022 Sep; 140():108828. PubMed ID: 35749919
[TBL] [Abstract][Full Text] [Related]
29. Prevalence and predictors of medication for opioid use disorder among reproductive-aged women.
Bello JK; Dell NA; Laxton AM; Conte M; Chen L
Drug Alcohol Depend Rep; 2024 Jun; 11():100239. PubMed ID: 38711835
[TBL] [Abstract][Full Text] [Related]
30. Impact of medications for opioid use disorder among persons hospitalized for drug use-associated skin and soft tissue infections.
Barocas JA; Gai MJ; Amuchi B; Jawa R; Linas BP
Drug Alcohol Depend; 2020 Oct; 215():108207. PubMed ID: 32795883
[TBL] [Abstract][Full Text] [Related]
31. Substance use severity as a predictor for receiving medication for opioid use disorder among adolescents: An analysis of the 2019 TEDS.
Welsh JW; Sitar SI; Hunter BD; Godley MD; Dennis ML
Drug Alcohol Depend; 2023 May; 246():109850. PubMed ID: 36989708
[TBL] [Abstract][Full Text] [Related]
32. Opioid use disorder incidence and treatment among incarcerated pregnant women in the United States: results from a national surveillance study.
Sufrin C; Sutherland L; Beal L; Terplan M; Latkin C; Clarke JG
Addiction; 2020 Nov; 115(11):2057-2065. PubMed ID: 32141128
[TBL] [Abstract][Full Text] [Related]
33. Descriptive Analysis of Inpatient and Outpatient Cohorts Seeking Treatment After Prescription Opioid Misuse and Medical Toxicology Evaluation.
Varney SM; Wiegand TJ; Wax PM; Brent J;
J Med Toxicol; 2021 Oct; 17(4):378-385. PubMed ID: 34402039
[TBL] [Abstract][Full Text] [Related]
34. Estimating the impact on initiating medications for opioid use disorder of state policies expanding Medicaid and prohibiting substance use during pregnancy.
Choi S; Stein MD; Raifman J; Rosenbloom D; Clark JA
Drug Alcohol Depend; 2021 Dec; 229(Pt A):109162. PubMed ID: 34768053
[TBL] [Abstract][Full Text] [Related]
35. Patterns of clinic switching and continuity of medication for opioid use disorder in a Medicaid-enrolled population.
Cole ES; Drake C; DiDomenico E; Sharbaugh M; Kim JY; Nagy D; Cochran G; Gordon AJ; Gellad WF; Pringle J; Warwick J; Chang CH; Kmiec J; Kelley D; Donohue JM
Drug Alcohol Depend; 2021 Apr; 221():108633. PubMed ID: 33631544
[TBL] [Abstract][Full Text] [Related]
36. Medications for opioid use disorder in pregnancy in a state women's prison facility.
Knittel AK; Zarnick S; Thorp JM; Amos E; Jones HE
Drug Alcohol Depend; 2020 Sep; 214():108159. PubMed ID: 32683223
[TBL] [Abstract][Full Text] [Related]
37. Community Attitudes Toward Opioid Use Disorder and Medication for Opioid Use Disorder in a Rural Appalachian County.
Beachler T; Zeller TA; Heo M; Lanzillotta-Rangeley J; Litwin AH
J Rural Health; 2021 Jan; 37(1):29-34. PubMed ID: 32738095
[TBL] [Abstract][Full Text] [Related]
38. Quality of Opioid Use Disorder Treatment for Persons With and Without Disabling Conditions.
Thomas CP; Stewart MT; Ledingham E; Adams RS; Panas L; Reif S
JAMA Netw Open; 2023 Mar; 6(3):e232052. PubMed ID: 36884250
[TBL] [Abstract][Full Text] [Related]
39. College students' perceived knowledge of and perceived helpfulness of treatments for opioid use disorder at two American universities.
Andraka-Christou B; Nguyen T; Harris S; Madeira J; Totaram R; Randall-Kosich O; Atkins D; Ford J
Am J Drug Alcohol Abuse; 2020 Sep; 46(5):589-603. PubMed ID: 32543922
[No Abstract] [Full Text] [Related]
40. Black clients in expansion states who used opioids were more likely to access medication for opioid use disorder after ACA implementation.
Johnson NL; Choi S; Herrera CN
J Subst Abuse Treat; 2022 Feb; 133():108533. PubMed ID: 34218991
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
